No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Zyter Acquires Casenet, LLC – Enhances Case Management, Disease Management, and Utilization Management Capabilities

Editor: What To Know

  • While Zyter already offers a number of payer products, the acquisition of Casenet adds more advanced capabilities in the areas of care management, disease management, utilization management and analytics.
  • Zyter will maintain the Casenet brand and TruCare care management products will continue to be marketed and sold as stand-alone offerings and in combination with Zyter.
  • These population health management products enable healthcare payers and providers to improve care coordination as well as the quality and delivery of care.

February 2, 2021

Zyter reports Casenet provides a comprehensive suite of enterprise care management software products for commercial, Medicaid, Medicare, TPA, provider/ACO and specialty provider organizations. These population health management products enable healthcare payers and providers to improve care coordination as well as the quality and delivery of care.

Currently Casenet’s TruCare products manage approximately 11% of the United States population.  Recognized as a market leader by KLAS, a leading research firm, Casenet products have been named Best in KLAS three years in a row for Software & Services (2017 and 2018) and Care Management Solutions (2019).

“Casenet is a care management market and technology leader,” said Sanjay Govil, founder and CEO of Zyter, Inc.  “This strategic acquisition adds capabilities that complement our expanding portfolio of digital health products for providers, patients and especially payers.”

With this acquisition, Casenet TruCare products will be enhanced with Zyter’s clinical collaboration, remote patient monitoring, and interoperability products, helping organizations improve operations and patient outcomes while reducing the overall cost of care.

While Zyter already offers a number of payer products, the acquisition of Casenet adds more advanced capabilities in the areas of care management, disease management, utilization management and analytics.  For example, Casenet’s TruCare Analytics application uses machine learning to model risk, identify populations, and provide segmentation so payers can make better, more informed care management decisions.

“This acquisition improves our ability to provide a 360-degree view of each member, making it easier for payers and providers to identify opportunities to coordinate and enhance care,” said Govil.

Zyter will maintain the Casenet brand and TruCare care management products will continue to be marketed and sold as stand-alone offerings and in combination with Zyter.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy